| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.13 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |